Tag: Parliamentary Question

  • Lord Palmer – 2016 Parliamentary Question to the HM Treasury

    Lord Palmer – 2016 Parliamentary Question to the HM Treasury

    The below Parliamentary question was asked by Lord Palmer on 2016-05-10.

    To ask Her Majesty’s Government how many times the cross-department ministerial group to tackle illicit trade in tobacco has met since it was announced in the budget of March 2015; and whether they will set out the membership of that group, the issues that were discussed at each meeting and the intended outcomes.

    Lord O’Neill of Gatley

    The cross-department ministerial group to tackle illicit tobacco will meet for the first time later this month. This follows a number of productive meetings between officials in HMRC and other departments to identify the challenges and opportunities in the UK and internationally and determine a clear agenda for ministerial action. Further details on the group will be issued in due course.

  • Lisa Nandy – 2016 Parliamentary Question to the Department for Energy and Climate Change

    Lisa Nandy – 2016 Parliamentary Question to the Department for Energy and Climate Change

    The below Parliamentary question was asked by Lisa Nandy on 2016-06-14.

    To ask the Secretary of State for Energy and Climate Change, what representations officials, advisers and Ministers in her Department made to the Competition and Markets Authority on the date of publication of its final report on the energy market.

    Andrea Leadsom

    The Competition and Markets Authority (CMA) are an independent body and the date of publication of their reports is their decision. Officials, Advisors and Ministers in the Department have not made any representations to the CMA, and the CMA have not consulted Ministers or advisors, on the date of the publication of this report. Officials in my Department have discussed with the CMA their intended date of publication for final report on the energy market to inform the Department’s own planning.

  • Keith Vaz – 2016 Parliamentary Question to the Department of Health

    Keith Vaz – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Keith Vaz on 2016-09-09.

    To ask the Secretary of State for Health, what progress has been made on reducing required variations in the care provided to people with diabetes.

    Nicola Blackwood

    This Government is working hard to improve outcomes and quality of life for those already living with diabetes and those who will develop it in the coming years. One of our key goals in the mandate to the National Health Service is a measurable reduction in variation in the management and care of people with the condition within the lifetime of this Parliament. Funding has been secured through the spending review to help achieve this and NHS England is developing a programme to ensure that those clinical commissioning groups (CCGs) which need extra investment in this area, accompanied by sound plans for delivery, receive it.

    In addition, the Clinical Commissioning Group Improvement and Assessment Framework will play a key role in delivering this as it contains two recognised evidence based measures of whether patients with diabetes are being supported to successfully manage their condition (achievement of the National Institute for Health and Care Excellence treatment targets and participation in structured education programmes).

    Using data from the NHS Atlas of Variation, NHS Right Care is also working with CCGs and other local partners to make improvements in diabetes care and reduce variation by providing hands on practical support.

    Since 2009/10, there has been an almost 70% increase in the proportion of people newly diagnosed with diabetes recorded as being referred to structured education courses, designed to help them manage their condition in the long term. However, whilst we know that the data on take up needs improving, there is still much further to go in enabling people with diabetes to access these programmes.

    The Department, NHS England and Diabetes UK are working on ways to improve the take up of structured education including exploring how more diversity of provision might be delivered through digital and web based approaches. The Department recently held a seminar with key stakeholders to identify actions that would facilitate improved access.

    CCGs are primarily responsible for commissioning diabetes services to meet the requirements of their population. In doing so, CCGs need to ensure that the services they provide are fit for purpose, reflect the needs of the local population, are based on the available evidence, taking into account national guidelines. This should include consideration of access to continuous glucose monitoring for people with Type 1 diabetes who might benefit from it.

  • Gregory Campbell – 2015 Parliamentary Question to the Department for Business, Innovation and Skills

    Gregory Campbell – 2015 Parliamentary Question to the Department for Business, Innovation and Skills

    The below Parliamentary question was asked by Gregory Campbell on 2015-10-28.

    To ask the Secretary of State for Business, Innovation and Skills, if he will hold discussions with motor trade associations on steps to ban the sale of devices that are used to illegally reduce car mileages on vehicles for resale.

    Nick Boles

    The Secretary of State for Business, Innovation and Skills has no plans to hold such a meeting.

    It is illegal to reduce the mileage on a car and advertise or sell it on that basis. This is the case regardless of the availability of devices that can reduce vehicle mileage. For advice on alleged offences of misleading advertising or fraud, consumers should approach Action Fraud or Citizens Advice, who may refer cases to Trading Standards.

  • Mark Hendrick – 2015 Parliamentary Question to the Department of Health

    Mark Hendrick – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Mark Hendrick on 2015-11-25.

    To ask the Secretary of State for Health, what steps Lancashire Teaching Hospitals NHS Foundation Trust is taking to ensure that registered nurses in its employment are able to comply fully with the requirements of revalidation with the Nursing and Midwifery Council; and what training is being provided to such nurses for that purpose.

    Ben Gummer

    Information on support provided by individual National Health Service providers is not collected centrally and may be obtained from the organisations themselves.

    All nurses and midwives practising in England are required by law to be registered with the Nursing and Midwifery Council. From April 2016, nurses and midwives will have to revalidate every three years, when they renew their registration.

    It is the responsibility of nurses and midwives to register and undertake revalidation.There is no specific requirement for employers to help nurses and midwives through revalidation but it is in their interests and a matter of good practice, to support nurses and midwives to provide safe and effective care.

    As part of its inspection process, the Care Quality Commission (CQC) considers staff access to training and related support. Where nurses are employed, the CQC makes enquiries about the maintenance of continual professional development and the levels of support offered by the provider.

  • Lord Greaves – 2016 Parliamentary Question to the HM Treasury

    Lord Greaves – 2016 Parliamentary Question to the HM Treasury

    The below Parliamentary question was asked by Lord Greaves on 2015-12-17.

    To ask Her Majesty’s Government which of their funding programmes are included within the Northern Powerhouse concept; and what is the estimate of the amount that will be spent by each department, and on what projects, in the current year and next.

    Lord O’Neill of Gatley

    Our Northern Powerhouse initiative aims to redress the imbalance between the North and the rest of the UK, and help the North in reaching its potential through investing across a wide range of areas. This includes spending £13 billion on transport, £46 billion on schools, and £150 billion on health in the North of England over the course of the next Spending Review period.

  • Gregory Campbell – 2016 Parliamentary Question to the Department of Health

    Gregory Campbell – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Gregory Campbell on 2016-01-27.

    To ask the Secretary of State for Health, if he will make changes to the clinical guidelines for motor neurone disease to improve diagnosis and treatment.

    George Freeman

    The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing robust, evidence-based guidance for the National Health Service. NICE is currently developing a clinical guideline on the assessment and management of motor neurone disease, and expects to publish its final guidance in February 2016. NICE is also producing a quality standard on motor neurone disease and its anticipated publication date is August 2016.

  • Louise Haigh – 2016 Parliamentary Question to the Department for Transport

    Louise Haigh – 2016 Parliamentary Question to the Department for Transport

    The below Parliamentary question was asked by Louise Haigh on 2016-02-24.

    To ask the Secretary of State for Transport, whether the comment by Peter Wilkinson, Director of Rail Passenger Services at his Department, of 22 February 2016, about future industrial relations between his Department and transport unions is accurate.

    Claire Perry

    The Department for Transport is committed to continuing to work constructively with the Transport Unions in the coming years to deliver the best possible transport services for all passengers, users and taxpayers.

  • Ben Bradshaw – 2016 Parliamentary Question to the Department of Health

    Ben Bradshaw – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Ben Bradshaw on 2016-03-15.

    To ask the Secretary of State for Health, what assessment his Department has made on the likely incidence of recurrent respiratory papillomatosis in the event that the (a) quadrivalent vaccine is maintained for UK HPV vaccination programme for girls and (b) bivalent vaccine is introduced for the UK HPV vaccination programme for girls.

    Jane Ellison

    The Department has not estimated the impact on the incidence of recurrent respiratory papillomatosis if the bivalent vaccine replaces the quadrivalent vaccine in the human papillomavirus (HPV) vaccination programme for girls.

    Warwick University is carrying out some limited analysis, in the context of its modelling work on the impact and cost effectiveness of extending HPV vaccination to boys, but the results are academically and commercially confidential, and subject to review by the Joint Committee on Vaccination and Immunisation, the independent expert body that advises Ministers on immunisation matters.

    Estimates of the potential impact of the HPV vaccination programme on cancer and warts, including the incidence of recurrent respiratory papillomatosis, have been previously published by Public Health England in the British Medical Journal in 2011:

    http://www.bmj.com/content/343/bmj.d5775

  • Andrew Bridgen – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    Andrew Bridgen – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Andrew Bridgen on 2016-04-08.

    To ask the Secretary of State for Foreign and Commonwealth Affairs, what estimate he has made of the number of Government officials engaged in matters relating to policies from the EU; and what the staff cost of such engagement is.

    Mr David Lidington

    Departments are appropriately resourced to support the Government’s priorities in Europe. The staff costs of engagement on EU business cannot be obtained without incurring disproportionate cost.